Diagnamed Holdings (DMED) Stock Overview

Diagnamed Holdings Corp., a biotechnology company, engages in the development and commercialization of digital therapeutics for people suffering from mental health and neurological disorders. It focuses on CERVAI, a brain health AI platform; and Health GenAI, a suite of generative AI solutions for the healthcare market that includes FormGPT.io, an AI Health form, as well as PalGPT.ai, a personal GPT companion. The company also develops Dr. GENAI that enables patients and practitioners to input vital signs, lab results, and medical data for analysis through a chat interface. In addition, it is developing BrainYear, an electroencephalogram-based (EEG) machine-learning solution to detect an individual's brain age for use in clinic and at-home; BrainTremor, a wearable device to detect tremors and brain activity for neurological disorders by EEG; and VR/AI Neuro, a virtual reality and artificial intelligence neurodiagnostic system for the evaluation, diagnosis, and monitoring of neurodegenerative diseases, such as Parkinson's disease. The company is headquartered in Toronto, Canada.